skip to main content
Idioma:
Você quis dizer: insulin therapeutic use?
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The diabetic life, its control by diet and insulin; a concise practical manual for practitioners and patients
Material Type:
Livro 		Adicionar ao Meu Espaço

The diabetic life, its control by diet and insulin; a concise practical manual for practitioners and patients

Robert Daniel Lawrence 1892-

London J. & A. Churchill Ltd. 1945

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (616.379-008.64 L422d )(Acessar)

2
Hypoglycemia
Hypoglycemia
Material Type:
Livro 		Adicionar ao Meu Espaço

Hypoglycemia

D Andreani (Domenico); Vincent Marks; P. J Lefèbvre 1934- (Pierre J.); International Symposium on Hypoglycemia (3rd 1986 Rome, Italy)

New York Raven Press c1987

Localização: FSP - Faculdade de Saúde Pública    (616.466 1 )(Acessar)

3
Real-world study of the concomitant use of biphasic insulin aspart 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes
Real-world study of the concomitant use of biphasic insulin aspart 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Real-world study of the concomitant use of biphasic insulin aspart 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes

Davies, Melanie ; Alibegovic, Amra Ciric ; Anil, Gayathri ; Braae, Uffe Christian ; Jensen, Anders Boeck ; Nordsborg, Rikke Baastrup

Diabetic medicine, 2024-05, Vol.41 (5), p.e15267-e15267 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Long‐acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
Long‐acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long‐acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

Horvath, Karl ; Jeitler, Klaus ; Berghold, Andrea ; Ebrahim, Susanne H ; Gratzer, Thomas W ; Plank, Johannes ; Kaiser, Thomas ; Pieber, Thomas R ; Siebenhofer, Andrea ; Horvath, Karl

Cochrane database of systematic reviews, 2007-04, Vol.2010 (1), p.CD005613-CD005613 [Periódico revisado por pares]

Chichester, UK: John Wiley & Sons, Ltd

Texto completo disponível

Citações Citado por
5
Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)
Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)

Vora, J. ; Cohen, N. ; Evans, M. ; Hockey, A. ; Speight, J. ; Whately-Smith, C.

Diabetes, obesity & metabolism, 2015-12, Vol.17 (12), p.1133-1141

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
Material Type:
Artigo 		Adicionar ao Meu Espaço

(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus

Semlitsch, Thomas ; Semlitsch, Thomas ; Engler, Jennifer ; Siebenhofer, Andrea ; Jeitler, Klaus ; Berghold, Andrea ; Horvath, Karl

Cochrane database of systematic reviews, 2020-11, Vol.2020 (11), p.CD005613 [Periódico revisado por pares]

Chichester, UK: John Wiley & Sons, Ltd

Texto completo disponível

Citações Citado por
7
The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial
The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial

Retnakaran, Ravi ; Ye, Chang ; Emery, Alexandra ; Kramer, Caroline K ; Zinman, Bernard

Nature communications, 2022-10, Vol.13 (1), p.6109-6109, Article 6109 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes
Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes

Franek, E. ; Haluzík, M. ; Canecki Varžić, S. ; Sargin, M. ; Macura, S. ; Zacho, J. ; Christiansen, J. S.

Diabetic medicine, 2016-04, Vol.33 (4), p.497-505 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
9
Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open‐label, 2:1 randomized, treat‐to‐target trial
Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open‐label, 2:1 randomized, treat‐to‐target trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open‐label, 2:1 randomized, treat‐to‐target trial

Yang, Wenying ; Ma, Jianhua ; Hong, Tianpei ; Liu, Ming ; Miao, Heng ; Peng, Yongde ; Wang, Changjiang ; Xu, Xiangjin ; Yang, Tao ; Nielsen, Anne M. ; Pan, Lili ; Liu, Weihong ; Zhao, Weigang

Diabetes, obesity & metabolism, 2019-07, Vol.21 (7), p.1652-1660

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
10
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial

Kaneko, Shizuka ; Chow, Francis ; Choi, Dong Seop ; Taneda, Shinji ; Hirao, Koichi ; Park, Yongsoo ; Andersen, Thomas Hasseriis ; Gall, Mari-Anne ; Christiansen, Jens Sandahl

Diabetes research and clinical practice, 2015-01, Vol.107 (1), p.139-147 [Periódico revisado por pares]

Ireland: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (43.625)
  2. magazinearticle  (143)
  3. Livros  (33)
  4. Anais de Congresso  (28)
  5. Web Resources  (26)
  6. Book Chapters  (6)
  7. Newsletter Articles  (2)
  8. Dissertações  (2)
  9. Resenhas  (1)
  10. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1967  (176)
  2. 1967Até1980  (2.007)
  3. 1981Até1994  (3.617)
  4. 1995Até2009  (14.562)
  5. Após 2009  (23.538)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (42.717)
  2. Japonês  (5.338)
  3. Alemão  (414)
  4. Francês  (328)
  5. Português  (195)
  6. Espanhol  (195)
  7. Holandês  (61)
  8. Chinês  (49)
  9. Sueco  (33)
  10. Russo  (32)
  11. Italiano  (32)
  12. Polonês  (24)
  13. Norueguês  (18)
  14. Dinamarquês  (16)
  15. Serbian  (12)
  16. Croatian  (10)
  17. Coreano  (7)
  18. Turco  (7)
  19. Hebraico  (6)
  20. Tcheco  (3)
  21. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Lefèbvre, P
  2. Marks, V
  3. International Symposium on Hypoglycemia
  4. Lawrence, R
  5. Andreani, D

Neste Assunto:

  1. Humans
  2. Science & Technology
  3. Life Sciences & Biomedicine
  4. Male
  5. Female

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.